Thromb Haemost 2000; 83(05): 769-776
DOI: 10.1055/s-0037-1613906
Review Article
Schattauer GmbH

Involvement of Activated Integrin α2β1 in the Firm Adhesion of Platelets onto a Surface of Immobilized Collagen under Flow Conditions

Masaaki Moroi
1   From the Department of Protein Biochemistry, Institute of Life Science, Kurume University, Kurume-shi, Fukuoka-ken, Japan
,
Ichiro Onitsuka
1   From the Department of Protein Biochemistry, Institute of Life Science, Kurume University, Kurume-shi, Fukuoka-ken, Japan
2   The Third Department of Internal Medicine, Faculty of Medicine, Kurume University, Kurume-shi, Fukuoka-ken, Japan
,
Tsutomu Imaizumi
2   The Third Department of Internal Medicine, Faculty of Medicine, Kurume University, Kurume-shi, Fukuoka-ken, Japan
,
Stephanie M. Jung
1   From the Department of Protein Biochemistry, Institute of Life Science, Kurume University, Kurume-shi, Fukuoka-ken, Japan
› Author Affiliations
We thank Dr. B. S. Coller (Mount Sinai School of Medicine, New York, NY) for the kind gift of antibodies, 6F1 and 10E5, and thank Drs. Yuji Saito and Junichi Takagi (Tokyo Institute of Technology, Tokyo, Japan) for the antibody TS2/16.
Further Information

Publication History

Received 31 December 1998

Accepted after revision 25 November 1999

Publication Date:
08 December 2017 (online)

Summary

Recently, we demonstrated that agonist-induced activation of the platelet surface collagen-receptor integrin α1 β2 converts it to an active form that can bind soluble collagen with high affinity (Jung, SM, Moroi, M: J Biol Chem 1998; 273: 14827-37). Here, the involvement of α2 β1 activation and the high affinity binding property of activated α2β1 in platelet adhesion to a collagen surface under flow conditions were analyzed. Platelet adhesion to immobilized collagen was measured in the presence of TS2/16, an activating anti-integrin α2β1 antibody, and inhibiting antibodies, Gi9 and 6F1. TS2/16 decreased the moving velocity of platelets on the collagen surface, but Gi9 and 6F1 increased it, indicating that α2β1 activation induces the tight binding of platelets to immobilized collagen under flow. Platelet adhesion, expressed as the surface area occupied by adhered platelets, in the presence of TS2/16 was similar to that in its absence. In contrast, adding Gi9 or 6F1 caused biphasic adhesion composed of a first phase, a lag phase whose length differed in each experiment, and a second phase adhesion with a rate similar to that of the control. This biphasic adhesion indicates that α2β1 activity is inhibited and also suggests that some other factor(s) may contribute to the adhesion under flow. At concentrations where neither 6F1 nor Gi9 affected collagen-induced aggregation, these antibodies inhibited soluble collagen binding to thrombin-activated platelets. Only at much higher concentration did 6F1 inhibit collagen-induced aggregation. TS2/16 had no effect on the aggregation. The present results are evidence against the major involvement of integrin α2β1 in platelet aggregation; instead, they indicate that integrin α2β1 would be mainly associated with the tight binding of platelets to collagen.

 
  • References

  • 1 Sakariassen KS, Aarts PAMM, De Groot PG, Houdijk WPM, Sixma JJ. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med 1983; 102: 522-35.
  • 2 Baumgartner HR, Turitto V, Weiss HJ. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. II. Relationships among platelet adhesion, thrombus dimensions, and fibrin formation. J Lab Clin Med 1980; 95: 208-21.
  • 3 Hubbell JA, McIntire LV. Visualization and analysis of mural thrombogenesis on collagen, polyurethane and nylon. Biomaterials 1986; 07: 354-63.
  • 4 Moroi M, Jung SM, Nomura S, Sekiguchi S, Ordinas A, Diaz-Ricart M. Analysis of the involvement of the von Willebrand factor-glycoprotein Ib interaction in platelet adhesion to a collagen-coated surface under flow conditions. Blood 1997; 90: 4413-24.
  • 5 Alevriadou BR, Moake JL, Turner NA, Ruggeri ZM, Folie BJ, Phillips MD, Schreiber AB, Hrinda ME, McIntire LV. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood 1993; 81: 1263-76.
  • 6 Wu Y-P, Van Breugel HHFI, Lankhof H, Wise RJ, Handin RI, De Groot PG, Sixma JJ. Platelet adhesion to multimeric and dimeric von Willebrand factor and to collagen type III preincubated with von Willebrand factor. Arterioscler Thromb Vasc Biol 1996; 16: 611-20.
  • 7 Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-97.
  • 8 Nieuwenhuis HK, Sakariassen KS, Houdijk WPM, Nievelstein PFEM, Sixma JJ. Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: A defect in platelet spreading. Blood 1986; 68: 692-5.
  • 9 Santoro SA. Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen. Cell 1986; 46: 913-20.
  • 10 Moroi M, Okuma M, Jung SM. Platelet adhesion to collagen-coated wells: Analysis of this complex process and a comparison with the adhesion to matrigel-coated wells. Biochim Biophys Acta 1992; 1137: 1-9.
  • 11 Saelman EUM, Nieuwenhuis HK, Hese KM, De Groot PG, Heijnen HFG, Sage EH, Williams S, McKeown L, Gralnick HR, Sixma JJ. Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GP Ia/IIa (α2β1-integrin). Blood 1994; 83: 1244-50.
  • 12 Kamata T, Puzon W, Takada Y. Identification of putative ligand binding sites within I domain of integrin α2β1 (VLA-2, CD49b/CD29). J Biol Chem 1994; 269: 9659-63.
  • 13 Tuckwell DS, Reid KBM, Barnes MJ, Humphries MJ. The A-domain of integrin α2 binds specifically to a range of collagens but is not a general receptor for the collagenous motif. Eur J Biochem 1996; 241: 732-9.
  • 14 Emsley J, King SL, Bergelson JM, Liddington RC. Crystal structure of the I domain from integrin α2β1. J Biol Chem 1997; 272: 28512-7.
  • 15 Jung SM, Moroi M. Platelets interact with soluble and insoluble collagens through characteristically different reactions. J Biol Chem 1998; 273: 14827-37.
  • 16 Coller BS, Beer JH, Scudder LE, Steinberg MH. Collagen-platelet interactions: Evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb/IIIa mediated by adhesive proteins. Blood 1989; 74: 182-92.
  • 17 Hemler ME, Sanchez-Madrid F, Flotte TJ, Krensky AM, Burakoff SJ, Bahn AK, Springer TA, Strominger JL. Glycoproteins of 210,000 and 130,000 m. w. on activated T cells: Cell distribution and antigenic relation to components on resting cells and T cell lines. J Immunol 1984; 132: 3011-8.
  • 18 Moroi M, Jung SM, Shinmyozu K, Tomiyama Y, Ordinas A, Diaz-Ricart M. Analysis of platelet adhesion to a collagen-coated surface under flow conditions: The involvement of glycoprotein VI in the platelet adhesion. Blood 1996; 88: 2081-92.
  • 19 Diaz-Ricart M, Carretero M, Castillo R, Ordinas A, Escolar G. Digital image analysis of platelet-extracellular matrix interactions: Studies in von Willebrand disease patients and aspirin-treated donors. Haemostasis 1994; 24: 219-29.
  • 20 Nieuwenhuis HK, Akkerman JWN, Houdijk WPM, Sixma JJ. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 1985; 318: 470-2.
  • 21 Sugiyama T, Okuma M, Ushikubi F, Sensaki S, Kanaji K, Uchino H. A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. Blood 1987; 69: 1712-20.
  • 22 Moroi M, Jung SM, Okuma M, Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 1989; 84: 1440-5.
  • 23 Kritzik M, Savage B, Nugent DJ, Santoso S, Ruggeri ZM, Kunicki TJ. Nucleotide polymorphisms in the α2 gene difine multiple alleles that are associated with differences in platelet α2β1 density. Blood 1998; 92: 2382-8.
  • 24 Verkleij MW, Morton LF, Knight CG, De Groot PG, Barnes MJ, Sixma JJ. Simple collagen-like peptides support platelet adhesion under static but not under flow conditions: Interaction via α2β1 and von Willebrand factor with specific sequences in native collagen is a requirement to resist shear forces. Blood 1998; 91: 3808-16.
  • 25 Kunicki TJ, Orchekowski R, Annis D, Honda Y. Variablity of integrin α2β1 activity on human platelets. Blood 1993; 82: 2693-703.
  • 26 Kunicki TJ, Kritzik M, Annis DS, Nugent DJ. Hereditary variation in platelet integrin α2β1 density is associated with two silent polymorphisms in the α2 gene coding sequence. Blood 1997; 89: 1939-43.
  • 27 Morton LF, Hargreaves PG, Farndale RW, Young RD, Barnes MJ. Integrin α2β1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for α2β1-independent platelet reactivity. Biochem J 1995; 306: 337-44.
  • 28 Asselin J, Gibbins JM, Achison M, Lee YH, Morton LF, Farndale RW, Barnes MJ, Watson SP. A collagen-like peptide stimulates tyrosine phosphorylation of syk and phopholipase Cγ2 in platelets independent of the integrin α2β1. Blood 1997; 89: 1235-42.
  • 29 Polgar J, Clemetson JM, Kehrel BE, Wiedemann M, Magnenat EM, Wells TNC, Clemetson KJ. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durussus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor. J Biol Chem 1997; 272: 13576-83.
  • 30 Jandrot-Perrus M, Lagrue A-H, Okuma M, Bon C. Adhesion and activation of human platelets induced by convulxin involve glycoprotein VI and integrin α2β1. J Biol Chem 1997; 272: 27035-41.